Acceptability Study of a New Paediatric Form of Vigabatrin in Infants and Children With Infantile Spasms or Pharmacoresistant Partial Epilepsy
Clinical trial NCT02220114 · COMPLETED
Trial details
- NCT number
- NCT02220114
- Sponsor
- Orphelia Pharma
- Status
- COMPLETED
- Phase
- Not Applicable
- Study type
- INTERVENTIONAL
- Start date
- 2014-05-01
- Primary completion
- 2016-12-01
- Enrollment
- 38
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.